175 related articles for article (PubMed ID: 24201857)
1. Sildenafil exposure and hemodynamic effect after Fontan surgery.
Tunks RD; Barker PC; Benjamin DK; Cohen-Wolkowiez M; Fleming GA; Laughon M; Li JS; Hill KD
Pediatr Crit Care Med; 2014 Jan; 15(1):28-34. PubMed ID: 24201857
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil exposure and hemodynamic effect after stage II single-ventricle surgery.
Hill KD; Tunks RD; Barker PC; Benjamin DK; Cohen-Wolkowiez M; Fleming GA; Laughon M; Li JS
Pediatr Crit Care Med; 2013 Jul; 14(6):593-600. PubMed ID: 23823195
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil improves exercise hemodynamics in Fontan patients.
Van De Bruaene A; La Gerche A; Claessen G; De Meester P; Devroe S; Gillijns H; Bogaert J; Claus P; Heidbuchel H; Gewillig M; Budts W
Circ Cardiovasc Imaging; 2014 Mar; 7(2):265-73. PubMed ID: 24478333
[TBL] [Abstract][Full Text] [Related]
4. Effects of escalating doses of sildenafil on hemodynamics and gas exchange in children with pulmonary hypertension and congenital cardiac defects.
Raja SG; Danton MD; MacArthur KJ; Pollock JC
J Cardiothorac Vasc Anesth; 2007 Apr; 21(2):203-7. PubMed ID: 17418732
[TBL] [Abstract][Full Text] [Related]
5. Effects of sildenafil citrate on human hemodynamics.
Jackson G; Benjamin N; Jackson N; Allen MJ
Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial.
Andersen MJ; Ersbøll M; Axelsson A; Gustafsson F; Hassager C; Køber L; Borlaug BA; Boesgaard S; Skovgaard LT; Møller JE
Circulation; 2013 Mar; 127(11):1200-8. PubMed ID: 23406672
[TBL] [Abstract][Full Text] [Related]
7. Impact of sildenafil on echocardiographic indices of myocardial performance after the Fontan operation.
Goldberg DJ; French B; Szwast AL; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
Pediatr Cardiol; 2012 Jun; 33(5):689-96. PubMed ID: 22331056
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of high dose generic sildenafil in Thai patients with pulmonary arterial hypertension.
Durongpisitkul K; Pornrattanarungsi S; Panjasamanvong P; Chungsomprasong P
J Med Assoc Thai; 2011 Apr; 94(4):421-6. PubMed ID: 21591526
[TBL] [Abstract][Full Text] [Related]
9. Modulation of pulmonary vascular resistance as a target for therapeutic interventions in Fontan patients: focus on phosphodiesterase inhibitors.
Ciliberti P; Schulze-Neick I; Giardini A
Future Cardiol; 2012 Mar; 8(2):271-84. PubMed ID: 22413985
[TBL] [Abstract][Full Text] [Related]
10. Sildenafil reduces pulmonary vascular resistance in single ventricular physiology.
Mori H; Park IS; Yamagishi H; Nakamura M; Ishikawa S; Takigiku K; Yasukochi S; Nakayama T; Saji T; Nakanishi T
Int J Cardiol; 2016 Oct; 221():122-7. PubMed ID: 27400308
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic impact of pulmonary vasodilators on single ventricle physiology.
Castaldi B; Bordin G; Padalino M; Cuppini E; Vida V; Milanesi O
Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29193758
[TBL] [Abstract][Full Text] [Related]
13. Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.
Schulze-Neick I; Hartenstein P; Li J; Stiller B; Nagdyman N; Hübler M; Butrous G; Petros A; Lange P; Redington AN
Circulation; 2003 Sep; 108 Suppl 1():II167-73. PubMed ID: 12970227
[TBL] [Abstract][Full Text] [Related]
14. Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.
Goldberg DJ; French B; McBride MG; Marino BS; Mirarchi N; Hanna BD; Wernovsky G; Paridon SM; Rychik J
Circulation; 2011 Mar; 123(11):1185-93. PubMed ID: 21382896
[TBL] [Abstract][Full Text] [Related]
15. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
Giardini A; Balducci A; Specchia S; Gargiulo G; Bonvicini M; Picchio FM
Eur Heart J; 2008 Jul; 29(13):1681-7. PubMed ID: 18534975
[TBL] [Abstract][Full Text] [Related]
16. Acute vasodilator testing following Fontan palliation: an opportunity to guide precision care?
Day RW
Cardiol Young; 2020 Jun; 30(6):829-833. PubMed ID: 32441233
[TBL] [Abstract][Full Text] [Related]
17. Sildenafil therapy for neonatal and childhood pulmonary hypertensive vascular disease.
Humpl T; Reyes JT; Erickson S; Armano R; Holtby H; Adatia I
Cardiol Young; 2011 Apr; 21(2):187-93. PubMed ID: 21138617
[TBL] [Abstract][Full Text] [Related]
18. Acute effect of sildenafil is maintained in pulmonary arterial hypertension patients chronically treated with bosentan.
Hatano M; Yao A; Kinugawa K; Hirata Y; Nagai R
Int Heart J; 2011; 52(4):233-9. PubMed ID: 21828950
[TBL] [Abstract][Full Text] [Related]
19. Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease.
Fraisse A; Butrous G; Taylor MB; Oakes M; Dilleen M; Wessel DL
Intensive Care Med; 2011 Mar; 37(3):502-9. PubMed ID: 21069290
[TBL] [Abstract][Full Text] [Related]
20. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
